Amundi’s MannKind Corp MNKD Stock Holding History

Amundi’s Portfolio MNKD Stock Details MNKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$374K	Buy	87,866 +35,475	+68%	+$115K	﹤0.01%	1756
2026 Q1	$128K	Buy	+52,391	New	+$234K	﹤0.01%	1943
2022 Q4	–	Sell	-24,407	Closed	-$77K	–	1950
2022 Q3	$77K	Hold	24,407	–	–	﹤0.01%	1599
2022 Q2	$94K	Buy	+24,407	New	+$89.7K	﹤0.01%	1457

Other funds holding MNKD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Amundi's MNKD Position: Q2 2026 in Review

Amundi increased its MannKind Corp (MNKD) stake by 68% in Q2 2026, buying an estimated $115K and bringing the position to 87,866 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #1756.

Amundi first reported a position in MNKD in Q2 2022 and has held it in 4 quarters since. 259 funds tracked by Wall St. Rank hold MNKD as of Q2 2026.

Amundi held 87,866 shares of MannKind Corp worth $374K as of Q2 2026.
Amundi bought 35,475 MannKind Corp shares in Q2 2026, an estimated $115K.
MannKind Corp made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1756 holding.
Amundi first reported a position in MannKind Corp in Q2 2022 and has held it in 4 quarters since.
259 funds tracked by Wall St. Rank held MannKind Corp as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.